Drilldown: Medicines - Pharmacopedia

Choose a table:

Medicines (732)

Medicines > classes

: Anticonvulsant

or Antipsychotic

or Dissociative

Use the filters below to narrow your results.

None (17)

Phenothiazine D2 antagonist (5) · NMDA antagonist (3) · NMDA antagonist; sigma receptor agonist (2) · Sodium channel blocker (2)

Other values:

None (55) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1)

None (55) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)

None (55) · 28 mg/device (each dose uses 2 devices) (1)

None (55) · 84 mg per session (1)

None (55) · Intranasal (under direct medical supervision) (1)

None (55) · Within hours of first administration (1)

None (55) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)

None (55) · ~7-12 hours (1)

None (55) · ~48% intranasal (1)

None (55) · Avoid; may cause fetal harm (1)

None (55) · Rx, Schedule III (US). REMS program required. (1)

Showing below up to 56 results in range #1 to #56.

2

2-FDCK

3

4

4-MeO-PCP

A

Asenapine

B

Brivaracetam

C

D

E

Ephenidine

F

I

L

M

N

Nitrous oxide

O

O-PCE

P

R

Rufinamide

S

T

V

X

Xenon

Z

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"